Delírio de Gravidez Secundário a Hiperprolactinémia Induzida por Antipsicóticos: Caso Clínico
DOI:
https://doi.org/10.51338/rppsm.689Palavras-chave:
Antipsicóticos, Aripiprazol, Delírios, Gravidez, HiperprolactinémiaResumo
Descrevemos o caso clínico de uma mulher de 33 anos de idade, com o diagnóstico de Esquizofrenia e quatro internamentos prévios em serviços agudos de Psiquiatria. Após o seu último internamento, aos 33 anos, a doente encontrava-se estável sob terapêutica com injetável de longa duração de palmitato de paliperidona 150mg mensal. Seis meses após a alta, ao longo do seguimento psiquiátrico, a doente apresentou um quadro caracterizado por delírio de gravidez e alucinações somáticas. Os resultados dos testes laboratoriais demonstraram hiperprolactinémia (185ng/mL) e valores negativos de HCG. Foi iniciada terapêutica com aripiprazol 5mg, que resultou na remissão de sintomas psicóticos ao fim de um mês.
Downloads
Referências
Das S, Prasad S, Kumar SA, Makonyonga RD, Saadoun M, Mergler R. Delusion of pregnancy: a case report and literature review. Clin Med Insights Case Rep. 2023;16:11795476231161169. doi: 10.1177/11795476231161169.
Bera SC, Sarkar S. Delusion of pregnancy: a systematic review of 84 cases in the literature. Indian J Psychol Med. 2015;37:131-7. doi: 10.4103/0253-7176.155609.
Seeman MV. Pseudocyesis, delusional pregnancy, and psychosis: the birth of a delusion. World J Clin Cases. 2014;2:338-44. doi: 10.12998/wjcc.v2.i8.338.
Sharma M, Singh R, Sahu S, Pruthi S. Delusion of pregnancy: case series. Indian J Psychiatry. 2024;66:576-80. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_699_23.
Gogia S, Grieb A, Jang A, Gordon MR, Coverdale J. Medical considerations in delusion of pregnancy: a systematic review. J Psychosom Obstet Gynaecol. 2022;43:51-7. doi: 10.1080/0167482X.2020.1779696.
Ahuja N, Moorhead S, Lloyd AJ, Cole AJ. Antipsychotic-induced hyperprolactinemia and delusion of pregnancy. Psychosomatics. 2008;49:163-7. doi: 10.1176/appi.psy.49.2.163.
Ali JA, Desai KD, Ali LJ. Delusions of pregnancy associated with increased prolactin concentrations produced by antipsychotic treatment. Int J Neuropsychopharmacol. 2003;6:111-5. doi: 10.1017/S1461145703003365.
Holt RIG. Medical causes and consequences of hyperprolactinaemia: a context for psychiatrists. J Psychopharmacol. 2008;22:28-37. doi: 10.1177/0269881107087951.
Cookson J, Hodgson R, Wildgust HJ. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis. J Psychopharmacol. 2012;26:42-51. doi: 10.1177/0269881112442016.
Qi-Lytle X, Sayers S, Wagner EJ. Current review of the function and regulation of tuberoinfundibular dopamine neurons. Int J Mol Sci. 2024;25:110. doi: 10.3390/ijms25010110.
Kesby JP, Eyles DW, McGrath JJ, Scott JG. Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. Transl Psychiatry. 2018;8:30. doi: 10.1038/s41398-017-0071-9.
de Bartolomeis A, Tomasetti C, Iasevoli F. Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism. CNS Drugs. 2015;29:773-99. doi: 10.1007/s40263-015-0278-3.
Hummer M, Huber J. Hyperprolactinaemia and antipsychotic therapy in schizophrenia. Curr Med Res Opin. 2004;20:189-97. doi: 10.1185/030079903125002865.
Tewksbury A, Olander A. Management of antipsychotic-induced hyperprolactinaemia. Ment Health Clin. 2016;6:185-90. doi: 10.9740/mhc.2016.07.185.
Hu LY, Lee YT, Lu T, Hung MB, Hung YY. Using aripiprazole to treat new-onset hyperprolactinaemia-related delusion of pregnancy. Aust N Z J Psychiatry. 2015;49:946. doi: 10.1177/0004867415589796.
Meng M, Li W, Zhang S, Wang H, Sheng J, Wang J, et al. Using aripiprazole to reduce antipsychotic-induced hyperprolactinaemia: meta-analysis of currently available randomized controlled trials. Shanghai Arch Psychiatry. 2015;27:4-17. doi: 10.11919/j.issn.1002-0829.215014.
Li X, Tang Y, Wang C. Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinaemia: meta-analysis of randomized controlled trials. PLoS One. 2013;8:e70179. doi: 10.1371/journal.pone.0070179.
Soomro F, Periasamy D, Isakov O, Aguilar-Henriquez A, Abzakh S. Efficacy of aripiprazole for the management of antipsychotic-induced hyperprolactinaemia: a retrospective case series. Int J Clin Stud Med Case Rep. 2024;41:001005. doi: 10.46998/IJCMCR.2024.41.001005.
Jiang Q, Li T, Zhao L, Sun Y, Mao Z, Xing Y, et al. Treatment of antipsychotic-induced hyperprolactinaemia: an umbrella review of systematic reviews and meta-analyses. Front Psychiatry. 2024;15:1337274. doi: 10.3389/fpsyt.2024.1337274.
